Century Therapeutics

United States
South Weldon, North Carolina, United States, 19104

Company profile

Century Therapeutics company profile

Century Therapeutics builds an allogeneic iPSC-derived cell therapy platform that integrates gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical needs.

Business identity

Contact email
[email protected]
Phone number
+1 267 857 1080
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
19104
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$755M
Last funding
Post IPO Equity / $135M / 2026-01-08
Last equity funding
Post IPO Equity / $135M
Investors
25
Lead investors
5
Founders
1
Articles
110
Exited on
2021-06-17

Founders and investors

Founders

Marcela Maus

Lead investors

Bain Capital Life SciencesBristol-Myers SquibbCasdin CapitalLeaps by BayerTCG Crossover

Investors

Adage Capital ManagementFidelityRA Capital ManagementRTW InvestmentsTCG Crossover